Nattokinase 10,800 FU: Fermentation, Enteric Delivery & Testing
Max D.Share
When choosing a cardiovascular support supplement, the ingredient label is only part of the picture. Nattokinase is an enzyme, so activity, formulation, delivery, and finished-product testing all matter when evaluating what is actually inside the bottle. Here is a closer look at the science behind nattokinase, the role of enteric delivery, and the independent verification standards used for Therexa Nattokinase 10,800 FU.
The Origin of Nattokinase: Beyond Traditional Food
Nattokinase is closely associated with natto, the traditional Japanese food made by fermenting soybeans. The enzyme itself, however, is not naturally present in unfermented soybeans. It is produced during fermentation by Bacillus subtilis var. natto and was first characterized for its strong fibrinolytic activity in research published in 1987 [1].

This distinction matters for supplements: a nattokinase product provides a standardized enzyme preparation rather than whole natto. Research over the following decades has continued to characterize nattokinase's fibrinolytic enzyme activity and the methods used to measure that activity [1, 2].
How Nattokinase Relates to the Fibrinolytic System
Fibrin is an insoluble protein that forms part of the structural framework of a blood clot. The body also has a natural fibrinolytic system that helps break down fibrin as part of normal clot regulation.
Nattokinase has demonstrated fibrinolytic enzyme activity in laboratory research, where its interaction with fibrin and fibrin-based substrates can be measured directly [1, 2]. This laboratory activity is also the basis for expressing nattokinase potency in activity units rather than by ingredient weight alone.
From Fermentation to a Standardized Enzyme
Commercial nattokinase production begins with controlled fermentation, followed by extraction and standardization of enzyme activity. For the finished Therexa product, the key specification is not simply how many milligrams of material are present, but the measured enzyme activity delivered per serving.

Therexa Nattokinase provides 540 mg of nattokinase standardized to 10,800 FU per serving [3]. More than a milligram number, 10,800 FU represents the defined enzymatic activity of the finished serving, giving consumers a measurable potency specification rather than relying on ingredient weight alone [2, 3].
Why Fibrinolytic Units (FU) Matter
Nattokinase potency is expressed in Fibrinolytic Units (FU), a measure of enzymatic activity rather than ingredient weight alone. Laboratory methods for nattokinase evaluate how actively the enzyme interacts with fibrin-based substrates, allowing enzyme preparations to be characterized by functional activity rather than simply by mass [2].
This distinction matters because milligrams tell you how much material is present, while FU describes the measured activity of that enzyme preparation. Two nattokinase products can therefore list a similar ingredient weight without necessarily providing the same stated enzyme activity.
For Therexa, each serving is standardized to 10,800 FU from 540 mg of nattokinase, making the activity specification directly visible on the label [3].
Enteric Delivery and the Gastric Environment
Nattokinase is a protein enzyme, and enzyme stability can be affected by the gastrointestinal environment. Research on enteric delivery systems for nattokinase has shown that an enteric coating can protect enzyme preparations in simulated gastric conditions and support delayed release under intestinal conditions [4].
Therexa Nattokinase 10,800 FU uses enteric-coated capsules designed to resist the acidic stomach environment and release later in the digestive tract [3]. This formulation choice is relevant because the labeled FU value describes the activity of the product as manufactured; delivery technology is intended to help protect that enzyme before release.†
Independent Testing and Published Product Documentation
Therexa states that every batch of its products is sent to independent, accredited laboratories in the United States for third-party testing. Its published quality program includes screening every batch for arsenic, cadmium, lead, mercury, and microbial contamination, with annual identity verification and access to Certificates of Analysis [5].

The Therexa Nattokinase product page also publishes product-specific testing documents under its Certificate of Analysis section, allowing customers to review available reports directly [3].
Clean Label Project Certification and Purity Award
Therexa Nattokinase 10,800 FU is listed as Clean Label Project Certified and has also earned the Clean Label Project Purity Award [3].
Clean Label Project describes a consumer-style sampling process in which products are purchased from retail or brand channels, then sent to ISO-accredited analytical laboratories. Depending on the category, testing can include heavy metals, more than 300 pesticides including glyphosate, plasticizers such as BPA, BPS, and phthalates, and other chemicals of concern [6].
The Purity Award adds a comparative benchmark. Clean Label Project states that products earning the award must perform among the top one-third of tested products in their category, together with meeting the program's additional compliance requirements [7].

These certifications relate to contaminant testing, purity benchmarking, and product-quality verification. They should not be interpreted as FDA approval or as independent confirmation of any therapeutic effect.
Read More: Want to see how Therexa goes beyond routine batch testing? Learn what Clean Label Project certification means for Therexa Nattokinase 10,800 FU , including independent contaminant testing and product-quality verification.
Suggested Use and Safety Considerations
Therexa Nattokinase contains 120 vegan capsules, providing a 60-day supply at the labeled serving size of two capsules per day [3].
Nattokinase has fibrinolytic properties, so people taking anticoagulant or antiplatelet medications, those with bleeding disorders, people who are pregnant or nursing, or anyone preparing for a medical procedure should speak with a qualified healthcare professional before use.
Experience Verifiable Quality
Therexa Nattokinase 10,800 FU combines a standardized enzyme activity level, enteric-coated delivery, published batch-testing documentation, and independent Clean Label Project certification. The goal is not simply to place another badge on the label, but to give consumers multiple ways to verify product specifications and quality information for themselves.
References
- Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia. 1987;43(10):1110–1111. Available at: https://pubmed.ncbi.nlm.nih.gov/3478223/
- Purification, fibrinolytic activity and substrate binding of nattokinase from Bacillus subtilis: A rapid and sensitive detection for fibrinolytic activity of nattokinase. 2024. Available at: https://pubmed.ncbi.nlm.nih.gov/39521221/
- Therexa Institute. Nattokinase 10,800 FU - Enteric Coated. Available at: https://therexa.co/products/nattokinase-10-800-fu-enteric-coated
- Law D, Zhang Z. Stabilization and target delivery of Nattokinase using compression coating. Drug Dev Ind Pharm. 2007;33(5):495–503. Available at: https://pubmed.ncbi.nlm.nih.gov/17520440/
- Therexa Institute. Certification — Every Batch. Tested. Published. Available at: https://therexa.co/pages/certification
- Clean Label Project. Clean Label Project Certification. Available at: https://cleanlabelproject.org/clean-label-project-certification/
- Clean Label Project. Awards & Certifications — Purity Award. Available at: https://cleanlabelproject.org/awards-certifications/
Disclaimer
† Structure/Function Claim Notice: Statements marked with † have not been evaluated by the Food and Drug Administration. Therexa Nattokinase 10,800 FU is not intended to diagnose, treat, cure, or prevent any disease.
Certification Scope: Clean Label Project certification and the Purity Award relate to Clean Label Project's contaminant-testing, purity, and benchmarking standards [6, 7]. They do not constitute FDA approval, medical certification, or verification of therapeutic efficacy.
Not Medical Advice: The content in this article is provided for general informational and educational purposes only and should not be construed as professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare professional before starting a new supplement regimen, particularly if you are pregnant, nursing, have a pre-existing medical condition, are preparing for a procedure, or are taking prescription medications.
Drug Interaction Warning: Nattokinase has fibrinolytic properties that may affect normal clotting mechanisms. Individuals taking anticoagulant or antiplatelet medications should consult a qualified healthcare professional before use.
Research Limitations: Scientific research on nattokinase continues to evolve. The cited studies do not constitute an endorsement of Therexa or any specific commercial product by the study authors or their institutions.